PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of headpainSpringerOpen.comSubmit OnlineRegisterThis journalThis article
 
J Headache Pain. 2008 April; 9(2): 57–69.
Published online 2008 March 15. doi:  10.1007/s10194-008-0026-x
PMCID: PMC2276243

The primary headaches: genetics, epigenetics and a behavioural genetic model

Abstract

The primary headaches, migraine with (MA) and without aura (MO) and cluster headache, all carry a substantial genetic liability. Familial hemiplegic migraine (FHM), an autosomal dominant mendelian disorder classified as a subtype of MA, is due to mutations in genes encoding neural channel subunits. MA/MO are considered multifactorial genetic disorders, and FHM has been proposed as a model for migraine aetiology. However, a review of the genetic studies suggests that the FHM genes are not involved in the typical migraines and that FHM should be considered as a syndromic migraine rather than a subtype of MA. Adopting the concept of syndromic migraine could be useful in understanding migraine pathogenesis. We hypothesise that epigenetic mechanisms play an important role in headache pathogenesis. A behavioural model is proposed, whereby the primary headaches are construed as behaviours, not symptoms, evolutionarily conserved for their adaptive value and engendered out of a genetic repertoire by a network of pattern generators present in the brain and signalling homeostatic imbalance. This behavioural model could be incorporated into migraine genetic research.

Full Text

The Full Text of this article is available as a PDF (263K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. The Compact English Dictionary, IInd edn. Oxford University Press, Oxford, pp 1–1378.
2. Headache Classification Subcommittee of the International Headache Society The international classification of headache disorders. Cephalalgia. 2004;24:1–160.
3. Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia. 1996;16:305–309. [PubMed]
4. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. The inheritance of migraine with aura estimated by means of structural equation modelling. J Med Genet. 1999;36:225–227. [PMC free article] [PubMed]
5. Russell MB, Ulrich V, Gervil M, Olesen J. Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache. 2002;42:332–336. [PubMed]
6. Devoto M, Lozito A, Staffa G, D’Alessandro R, Sacquegna T, Romeo G. Segregation analysis of migraine in 128 families. Cephalalgia. 1986;6:101–105. [PubMed]
7. Mochi M, Sangiorgi S, Cortelli P, Carelli V, Scapoli C, Crisci M, Monari L, Pierangeli G, Montagna P. Testing models for genetic determination in migraine. Cephalalgia. 1993;13:389–394. [PubMed]
8. Ulrich V, Russell MB, Ostergaard S, Olesen J. Analysis of 31 families with an apparently autosomal-dominant transmission of migraine with aura in the nuclear family. Am J Med Genet. 1997;74:395–397. [PubMed]
9. Merikangas KR, Merikangas JR, Angst J. Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res. 1993;27:197–210. [PubMed]
10. Mortimer MJ, Kay J, Jaron A, Good PA. Does a history of maternal migraine or depression predispose children to headache and stomach-ache? Headache. 1992;32:353–355. [PubMed]
11. Chen TC, Leviton A. Asthma and eczema in children born to women with migraine. Arch Neurol. 1990;47:1227–1230. [PubMed]
12. Mortimer MJ, Kay J, Gawkrodger DJ, Jaron A, Barker DC. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache. 1993;33:427–431. [PubMed]
13. Gurkan F, Ece A, Haspolat K, Dikici B. Parental history of migraine and bronchial asthma in children. Allergol Immunopathol (Madr) 2000;28:15–17. [PubMed]
14. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbio A, Maciazek J, Meyer B, Bach MA, Weissenbach J, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40–45. [PubMed]
15. Ophoff RA, Terwindt GM, Vergouwe MN, Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, Ommen GJ, Hofker MH, Ferrari MD, Frants RR. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543–552. [PubMed]
16. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997;15:62–69. [PubMed]
17. Alonso I, Barros J, Tuna A, Seixas A, Coutinho P, Sequeiros J, Silveira I. A novel R1347Q mutation in the predicted voltage sensor segment of the P/Q-type calcium-channel alpha-subunit in a family with progressive cerebellar ataxia and hemiplegic migraine. Clin Genet. 2004;65:70–72. [PubMed]
18. Subramony SH, Schott K, Raike RS, Callahan J, Langford LR, Christova PS, Anderson JH, Gomez CM. Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits. Ann Neurol. 2003;54:725–731. [PubMed]
19. Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, Hanna MG. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet. 2001;358:801–807. [PubMed]
20. Kors EE, Melberg A, Vanmolkot KR, Kumlien E, Haan J, Raininko R, Flink R, Ginjaar HB, Frants RR, Ferrari MD, Maagdenberg AM. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology. 2004;63:1136–1137. [PubMed]
21. Beauvais K, Cave-Riant F, Barace C, Tardieu M, Tournier-Lasserve E, Furby A. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur Neurol. 2004;52:58–61. [PubMed]
22. Spranger M, Spranger S, Schwab S, Benninger C, Dichgans M. Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur Neurol. 1999;41:150–152. [PubMed]
23. Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol. 2002;44:490–493. [PubMed]
24. Maselli RA, Kong DZ, Bowe CM, McDonald CM, Ellis WG, Agius MA, Gomez CM, Richman DP, Wollmann RL. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology. 2000;57:279–289. [PubMed]
25. Plomp JJ, Vergouwe MN, Maagdenberg AM, Ferrari MD, Frants RR, Molenaar PC. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain. 2000;123(Pt 3):463–471. [PubMed]
26. Kaja S, Ven RC, Broos LA, Veldman H, Dijk JG, Verschuuren JJ, Frants RR, Ferrari MD, Maagdenberg AM, Plomp JJ. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience. 2005;135:81–95. [PubMed]
27. Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants RR, Ferrari MD. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur J Hum Genet. 1998;6:297–307. [PubMed]
28. Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LAM, Cesetti T, Ven RCG, Tottene A, Kaa J, Plomp JJ, Frants RR, Ferrari MD. A Cacna1A knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41:701–710. [PubMed]
29. Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology. 1997;49:1231–1238. [PubMed]
30. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, Verier A, Echenne B, Lopez de Munain A, Bousser MG, Tournier-Lasserve E. Mapping of a second locus for familial hemiplegic migraine to 1q21–q23 and evidence of further heterogeneity. Ann Neurol. 1997;42:885–890. [PubMed]
31. Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha 2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33:192–196. [PubMed]
32. Riant F, Fusco M, Aridon P, Ducros A, Ploton C, Marchelli F, Maciazek J, Bousser MG, Casari G, Tournier-Lasserve E. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum Mutat. 2005;26:281. [PubMed]
33. Pierelli F, et al. A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia. 2006;26:324–328. [PubMed]
34. Echenne B, Ducros A, Rivier F, Joutel A, Humbertclaude V, Roubertie A, Azais M, Bousser MG, Tournier-Lasserve E. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics. 1999;30:214–217. [PubMed]
35. Vanmolkot KR, Kors EE, Hottenga JJ, Terwindt GM, Haan J, Hoefnagels WA, Black DF, Sandkuijl LA, Frants RR, Ferrari MD, Maagdenberg AM. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003;54:360–366. [PubMed]
36. Cevoli S, Pierangeli G, Monari L, Valentino ML, Bernardoni P, Mochi M, Cortelli P, Montagna P. Familial hemiplegic migraine: clinical features and probable linkage to chromosome 1 in an Italian family. Neurol Sci. 2002;23:7–10. [PubMed]
37. Jurkat-Rott K, Freilinger T, Dreier JP, Herzog J, Gobel H, Petzold GC, Montagna P, Gasser T, Lehmann-Horn F, Dichgans M. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology. 2004;62:1857–1861. [PubMed]
38. Spadaro M, Ursu S, Lehmann-Horn F, Liana V, Antonini G, Giunti P, Frontali M, Jurkat-Rott K. A G301R Na+/K+ ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics. 2004;5:177–185. [PubMed]
39. Vanmolkot KR, Stroink H, Koenderink JB, Kors EE, Heuvel JJ, Boogerd EH, Stam AH, Haan J, Vries BB, Terwindt GM, Frants RR, Ferrari MD, Maagdenberg AM. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann Neurol. 2006;59:310–314. [PubMed]
40. Bassi MT, Bresolin N, Tonelli A, Nazos K, Crippa F, Baschirotto C, Zucca C, Bersano A, Dolcetta D, Boneschi FM, Barone V, Casari G. A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet. 2004;41:621–628. [PMC free article] [PubMed]
41. Auvin S, Joriot-Chekaf S, Cuvellier JC, Vallee L. Familial alternating hemiplegia of childhood or channelopathy? A report with valuable pathophysiological implications. Dev Med Child Neurol. 2004;46:500. [PubMed]
42. Swoboda KJ, Kanavakis E, Xaidara A, Johnson JE, Leppert MF, Schlesinger-Massart MB, Ptacek LJ, Silver K, Youroukos S. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann Neurol. 2004;55:884–887. [PubMed]
43. Ambrosini A, D'Onofrio M, Grieco GS, Di Mambro A, Montagna G, Fortini D, Nicoletti F, Nappi G, Sances G, Schoenen J, Buzzi MG, Santorelli FM, Pierelli F. Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology. 2005;65:1826–1828. [PubMed]
44. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz B, Biskup S, Ferrari MD, Herzog J, Maagdenberg AM, Pusch M, Strom TM. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;366:371–377. [PubMed]
45. Terwindt G, et al. Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. Arch Neurol. 2002;59:1016–1018. [PubMed]
46. May A, et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet. 1995;96:604–608. [PubMed]
47. Nyholt DR, et al. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology. 1998;50:1428–1432. [PubMed]
48. Terwindt GM, et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology. 2001;56:1028–1032. [PubMed]
49. Hovatta I, et al. Familial migraine: exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine on 19p. Genomics. 1994;23:707–709. [PubMed]
50. Monari L, et al. Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital J Neurol Sci. 1997;18:277–282. [PubMed]
51. Kim JS, et al. Familial migraine with vertigo: no mutations found in CACNA1A. Am J Med Genet. 1998;79:148–151. [PubMed]
52. Brugnoni R, et al. Is the CACNA1A gene involved in familial migraine with aura? Neurol Sci. 2002;23:1–5. [PubMed]
53. Noble-Topham S, et al. Migraine with aura is not linked to the FHM gene CACNA1A or the chromosomal region, 19p13. Genomics. 2001;78:150–154. [PubMed]
54. Jones KW, et al. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Neurology. 2002;59:1099–1101. [PubMed]
55. Wieser T, et al. Absence of known familial hemiplegic migraine (FHM) mutations in the CACNA1A gene in patients with common migraine: implications for genetic testing. Clin Chem Lab Med. 2003;41:272–275. [PubMed]
56. Todt U, et al. Rare missense variants in ATP1A2 in families with clustering of common forms of migraine. Hum Mutat. 2005;26:315–321. [PubMed]
57. Lea RA, et al. A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics. 2002;4:17–22. [PubMed]
58. Curtain RP, et al. Analysis of chromosome 1 microsatellite markers and the FHM2-ATP1A2 gene mutations in migraine pedigrees. Neurol Res. 2005;27:647–652. [PubMed]
59. Jen JC, Kim GW, Dudding KA, Baloh RW. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch Neurol. 2004;61:926–928. [PubMed]
60. Kirchmann M, et al. The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. Am J Med Genet B Neuropsychiatr Gen. 2006;141:250–256.
61. Netzer C, et al. Haplotype-based systematic association studies of ATP1A2 in migraine with aura. Am J Med Genet. 2006;141:257–260. [PubMed]
62. Brevern M, et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache. 2006;46:1136–1141. [PubMed]
63. Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, Nonaka I. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology. 1992;42:545–550. [PubMed]
64. Montagna P, Gallassi R, Medori R, Govoni E, Zeviani M, Di Mauro S, Lugaresi E, Andermann F. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology. 1988;38:751–754. [PubMed]
65. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, Levasseur M, Homeyer P, Mas JL, Lyon-Caen O, Tournier Lasserve E, Bousser MG. Clinical spectrum of CADASIL: a study of 7 families. Lancet. 1995;346:934–939. [PubMed]
66. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731–739. [PubMed]
67. Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sandkuijl LA, Terwindt GM, Haan J, Maagdenberg AMJM, Jen J, Baloh RW, Barilla-LaBarca M-L, Saccone NL, Atkinson JP, Ferrari MD, Freimer NB, Frants RR. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1–p21.3. Am J Hum Genet. 2001;69:447–453. [PubMed]
68. Michael JC, Levin PM. Multiple telangiectases of brain: a discussion of hereditary factors in their development. Arch Neurol Psychiatry. 1936;36:514–536.
69. Marini V, Ferrera L, Dorcaratto A, Viale G, Origone P, Mareni C, Garrè C. Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test. J Neurol Sci. 2003;212:75–78. [PubMed]
70. Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hämäläinen E, Broas P, Joslyn G, Hovatta I, Hiekkalinna T, Kaprio J, Ott J, Cantor RM, Zwart JA, Ilmavirta M, Havanka H, Färkkilä M, Peltonen L, Palotie A. A susceptibility locus for migraine with aura on chromosome 4q24. Am J Hum Genet. 2002;70:652–62. [PubMed]
71. Cader ZM, Noble-Topham S, Dyment DA, Cherny SS, Brown JD, Rice GP, Ebers GC. Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet. 2003;12:2511–2517. [PubMed]
72. Russo L, Mariotti P, Sangiorgi E, Giordano T, Ricci I, Lupi F, Chiera R, Guzzetta F, Neri G, Gurrieri F. A new susceptibility locus for migraine with aura in the 15q11–q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet. 2005;76:327–333. [PubMed]
73. Carlsson A, Forsgren L, Nylander PO, Hellman U, Forsman-Semb K, Holmgren G, Holmberg D, Holmberg M. Identification of a susceptibility locus for migraine with and without aura on 6p12.2–p21.1. Neurology. 2002;59:1804–1807. [PubMed]
74. Nyholt DR, Morley KI, Ferreira MA, Medland SE, Boomsma DI, Heath AC, Merikangas KR, Montgomery GW, Martin NG. Genomewide significant linkage to migrainous headache on chromosome 5q21. Am J Hum Genet. 2005;77:500–512. [PubMed]
75. Soragna D, Vettori A, Carraro G, Marchioni E, Vazza G, Bellini S, Tupler R, Savoldi F, Mostacciuolo ML. A locus for migraine without aura maps on chromosome 14q21.2–q22.3. Am J Hum Genet. 2003;72:161–167. [PubMed]
76. Nyholt DR, Curtain RP, Griffiths LR. Familial typical migraine: significant linkage and localization of a gene to Xq24–28. Hum Genet. 2000;107:18–23. [PubMed]
77. McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, Peroutka SJ, Griffiths LR, Boyd PR, Lea RA, Bhatti SM, Hosking LK, Hood CM, Jones KW, Handley AR, Rallan R, Lewis KF, Yeo AJ, Williams PM, Priest RC, Khan P, Donnelly C, Lumsden SM, O’Sullivan J, See CG, Smart DH, Shaw-Hawkins S, Patel J, Langrish TC, Feniuk W, Knowles RG, Thomas M, Libri V, Montgomery DS, Manasco PK, Xu CF, Dykes C, Humphrey PP, Roses AD, Purvis IJ. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics. 2001;78:135–149. [PubMed]
78. Curtain R, Tajouri L, Lea R, MacMillan J, Griffiths L. No mutations detected in the INSR gene in a chromosome 19p13 linked migraine pedigree. Eur J Med Genet. 2006;49:57–62. [PubMed]
79. Cupini LM, Massa R, Floris R, Manenti G, Martini B, Tessa A, Nappi G, Bernardi G, Santorelli FM. Migraine-like disorder segregating with mtDNA 14484 Leber hereditary optic neuropathy mutation. Neurology. 2003;60:717–719. [PubMed]
80. Ojaimi J, Katsabanis S, Bower S, Quigley A, Byrne E. Mitochondrial DNA in stroke and migraine with aura. Cerebrovasc Dis. 1998;8:102–106. [PubMed]
81. Majamaa K, Finnilä S, Turkka J, Hassinen IE. Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet. 1998;352:455–456. [PubMed]
82. Boles RG, Williams JC. Mitochondrial disease and cyclic vomiting syndrome. Dig Dis Sci. 1999;44:103S–107S. [PubMed]
83. Boles RG, Adams K, Ito M, Li BU. Maternal inheritance in cyclic vomiting syndrome with neuromuscular disease. Am J Med Genet A. 2003;120:474–482. [PubMed]
84. Salpietro CD, Briuglia S, Merlino MV, Di Bella C, Rigoli L. A mitochondrial DNA mutation (A3243G mtDNA) in a family with cyclic vomiting. Eur J Pediatr. 2003;162:727–728. [PubMed]
85. Russell MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia. 1999;19:207–210. [PubMed]
86. Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol. 2006;13:1009–1013. [PubMed]
87. Mochi M, Cevoli S, Cortelli P, Pierangeli G, Scapoli C, Soriani S, Montagna P. Investigation of an LDLR gene polymorphism (19p13.2) in susceptibility to migraine without aura. J Neurol Sci. 2003;213:7–10. [PubMed]
88. Curtain R, Lea RA, Quinlan S, Bellis C, Tajouri L, Hughes R, Macmillan J, Griffiths LR. Investigation of the low-density lipoprotein receptor gene and cholesterol as a risk factor for migraine. J Neurol Sci. 2004;227:95–100. [PubMed]
89. D’Amico D, Moschiano F, Leone M, Ariano C, Ciusani E, Erba N, Grazzi L, Ferraris A, Schieroni F, Bussone G. Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia. 1998;18:618–621. [PubMed]
90. Haan J, Kappelle LJ, Ronde H, Ferrari MD, Bertina RM. The factor V Leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarction. Cephalalgia. 1997;17:605–607. [PubMed]
91. Corral J, Iniesta JA, González-Conejero R, Lozano ML, Rivera J, Vicente V. Migraine and prothrombotic genetic risk factors. Cephalalgia. 1998;18:257–260. [PubMed]
92. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF. Frequency of factor V Leiden in juvenile migraine with aura. Headache. 1998;38:779–781. [PubMed]
93. Haan J, Kappelle LJ, Ferrari MD, Bertina RM. The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with migrainous infarction. Cephalalgia. 1998;18:229–230. [PubMed]
94. Iniesta JA, Corral J, González-Conejero R, Díaz Ortuño A, Martínez Navarro ML, Vicente V. Role of factor XIII Val 34 Leu polymorphism in patients with migraine. Cephalalgia. 2001;21:837–841. [PubMed]
95. Paterna S, Di Pasquale P, D’Angelo A, Seidita G, Tuttolomondo A, Cardinale A, Maniscalchi T, Follone G, Giubilato A, Tarantello M, Licata G. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 2000;43:133–136. [PubMed]
96. Griffiths LR, Nyholt DR, Curtain RP, Goadsby PJ, Brimage PJ. Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology. 1997;49:614–617. [PubMed]
97. Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Griffiths LR. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet. 2001;105:110–113. [PubMed]
98. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alpérovitch A. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology. 2001;56:1273–1277. [PubMed]
99. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000;96:762–764. [PubMed]
100. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003;111:84–90. [PubMed]
101. Oterino A, Valle N, Pascual J, Bravo Y, Muñoz P, Castillo J, Ruiz-Alegría C, Sánchez- Velasco P, Leyva-Cobián F, Cid C. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele. Brain Res Mol Brain Res. 2005;139:163–168. [PubMed]
102. Ogilvie AD, Russell MB, Dhall P, Battersby S, Ulrich V, Smith CA, Goodwin GM, Harmar AJ, Olesen J. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia. 1998;18:23–26. [PubMed]
103. Borroni B, Brambilla C, Liberini P, Rao R, Archetti S, Gipponi S, Volta GD, Padovani A. Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J Headache Pain. 2005;6:182–184. [PMC free article] [PubMed]
104. Yilmaz M, Erdal ME, Herken H, Cataloluk O, Barlas O, Bayazit YA. Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci. 2001;186:27–30. [PubMed]
105. Juhasz G, Zsombok T, Laszik A, Gonda X, Sotonyi P, Faludi G, Bagdy G. Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet. 2003;17:231–240. [PubMed]
106. Monari L, Mochi M, Valentino ML, Arnaldi C, Cortelli P, Monte A, Pierangeli G, Prologo G, Scapoli C, Soriani S, Montagna P. Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital J Neurol Sci. 1997;18:277–282. [PubMed]
107. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR. Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenet. 2000;3:35–40.
108. Erdal ME, Herken H, Yilmaz M, Bayazit YA. Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci. 2001;188:99–101. [PubMed]
109. Nyholt DR, Curtain RP, Gaffney PT, Brimage P, Goadsby PJ, Griffiths LR. Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor gene. Cephalalgia. 1996;16:463–467. [PubMed]
110. Buchwalder A, Welch SK, Peroutka SJ. Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine. Headache. 1996;36:254–258. [PubMed]
111. Johnson MP, Lea RA, Curtain RP, MacMillan JC, Griffiths LR. An investigation of the 5-HT2C receptor gene as a migraine candidate gene. Am J Med Genet B Neuropsychiatr Genet. 2003;117:86–89. [PubMed]
112. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Cirgulation. 1998;98:25–30.
113. MaassenVanDenBrink A, Vergouve MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR. 5-HT1B receptor polymorphism and clinical response to sumatriptan. Headache. 1998;38:288–291. [PubMed]
114. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med. 1998;4:14–21. [PMC free article] [PubMed]
115. Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology. 1998;51:781–786. [PubMed]
116. Dichgans M, Förderreuther S, Deiterich M, Pfaffenrath V, Gasser T. The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology. 1998;51(3):928. [PubMed]
117. Montagna P, Cevoli S, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Mochi M. The genetics of chronic headaches. Neurol Sci. 2003;24:S51–S56. [PubMed]
118. Maude S, Curtin J, Breen G, Collier D, Russell G, Shaw D, Clair DS. The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson’s disease. Psychiatr Genet. 2001;11:49–52. [PubMed]
119. Rebaudengo N, Rainero I, Parziale A, Rosina F, Pavanelli E, Rubino E, Mazza C, Ostacoli L, Furlan PM. Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine. Cephalalgia. 2004;24:503–507. [PubMed]
120. Shepherd AG, Lea RA, Hutchins C, Jordan KL, Brimage PJ, Griffiths LR. Dopamine receptor genes and migraine with and without aura: an association study. Headache. 2002;42:346–351. [PubMed]
121. Marziniak M, Mössner R, Benninghoff J, Syagailo YV, Lesch KP, Sommer C. Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine. J Neural Transm. 2004;111:603–609. [PubMed]
122. Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths LR. Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci. 2006;251:118–123. [PubMed]
123. Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci. 2003;23:301–305. [PubMed]
124. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. Investigation of hormone receptor genes in migraine. Neurogenetics. 2005;6:17–23. [PubMed]
125. Mössner R, Weichselbaum A, Marziniak M, Freitag CM, Lesch KP, Sommer C, Meyer J. A highly polymorphic poly-glutamine stretch in the potassium channel KCNN3 in migraine. Headache. 2005;45:132–136. [PubMed]
126. Curtain R, Sundholm J, Lea R, Ovcaric M, MacMillan J, Griffiths L. Association analysis of a highly polymorphic CAG Repeat in the human potassium channel gene KCNN3 and migraine susceptibility. BMC Med Genet. 2005;14:32–39. [PMC free article] [PubMed]
127. Lulli P, Trabace S, Morellini M, Cicciarelli G, Coloprisco G, Piane M, Filippis S, Santi PG, Avramakou O, Ferlicca E, Martelletti P. Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A > G) and migraine. J Headache Pain. 2005;6:188–190. [PMC free article] [PubMed]
128. Rainero I, Fasano E, Rubino E, Rivoiro C, Valfrè W, Gallone S, Savi L, Gentile S, Lo Giudice R, Martino P, Dall’Omo AM, Pinessi L. Association between migraine and HLA-DRB1 gene polymorphisms. J Headache Pain. 2005;6:185–187. [PMC free article] [PubMed]
129. Couturier EG, Hering R, Steiner TJ. The first report of cluster headache in identical twins. Neurology. 1991;41:761. [PubMed]
130. Roberge C, Bouchard JP, Simard D, Gagné R. Cluster headache in twins. Neurology. 1992;42:1255–1256. [PubMed]
131. Schuh-Hofer S, Meisel A, Reuter U, Arnold G. Monozygotic twin sisters suffering from cluster headache and migraine without aura. Neurology. 2003;60:1864–1865. [PubMed]
132. Sjaastad O, Shen JM, Stovner LJ, Elsås T. Cluster headache in identical twins. Headache. 1993;33:214–217. [PubMed]
133. Spierings EL, Vincent AJ. Familial cluster headache: occurrence in three generations. Neurology. 1992;42:1399–1400. [PubMed]
134. Alberca R, Aguilera JM, Casado JL, López JM, Arenas C, Moreno A, Serrano V. Cluster headache with a familial presentation. Neurologia. 1994;9:22–24. [PubMed]
135. Bordini CA, Arruda MA, Ciciarelli M, Daripa M, Martins Coelho J, Speciali JG. Cluster headache: report of seven cases in three families. Funct Neurol. 1997;12:277–282. [PubMed]
136. D’Amico D, Leone M, Moschiano F, Bussone G. Familial cluster headache: report of three families. Headache. 1996;36:41–43. [PubMed]
137. Simone R, Fiorillo C, Bonuso S, Castaldo G. A cluster headache family with possible autosomal recessive inheritance. Neurology. 2003;61:578–579. [PubMed]
138. Russell MB, Andersson PG, Thomsen LL. Familial occurrence of cluster headache. J Neurol Neurosurg Psychiatry. 1995;58:341–343. [PMC free article] [PubMed]
139. Russell MB, Andersson PG, Thomsen LL, Iselius L. Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis. J Med Genet. 1995;32:954–956. doi: 10.1136/jmg.32.12.954. [PMC free article] [PubMed] [Cross Ref]
140. Russell MB, Andersson PG, Iselius L. Cluster headache is an inherited disorder in some families. Headache. 1996;36:608–612. [PubMed]
141. Montagna P, Mochi M, Prologo G, Sangiorgi S, Pierangeli G, Cavoli S, Cortelli P. Heritability of cluster headache. Eur J Neurol. 1998;5:343–345.
142. Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurol. 2004;3:279–283. [PubMed]
143. El Amrani M, Ducros A, Boulan P, Aidi S, Crassard I, Visy JM, Tournier-Lasserve E, Bousser MG. Familial cluster headache: a series of 186 index patients. Headache. 2002;42:974–977. [PubMed]
144. Svensson D, Ekbom K, Pedersen NL, Träff H, Waldenlind E. A note on cluster headache in a population-based twin register. Cephalalgia. 2003;23:376–380. [PubMed]
145. Shimomura T, Kitano A, Marukawa H, Mishima K, Isoe K, Adachi Y, Takahashi K. Point mutation in platelet mitochondrial tRNA (Leu(UUR)) in patient with cluster headache. Lancet. 1994;344:625. [PubMed]
146. Cortelli P, Zacchini A, Barboni P, Malpassi P, Carelli V, Montagna P. Lack of association between mitochondrial tRNA(Leu(UUR)) point mutation and cluster headache. Lancet. 1995;345:1120–1121. [PubMed]
147. Seibel P, Grünewald T, Gundolla A, Diener HC, Reichmann H. Investigation on the mitochondrial transfer RNA(Leu)(UUR) in blood cells from patients with cluster headache. J Neurol. 1996;243:305–307. [PubMed]
148. Odawara M, Tamaoka A, Mizusawa H, Yamashita K. A case of cluster headache associated with mitochondrial DNA deletions. Muscle Nerve. 1997;20:394–395. [PubMed]
149. Cuypers J, Altenkirch H. HLA antigens in cluster headache. Headache. 1979;19:228–229. [PubMed]
150. Martelletti P, Romiti A, Gallo MF, Giacovazzo M, Adorno D, Valeri M, Piazza A, Monaco PI, Casciani CU. HLA-B14 antigen in cluster headache. Headache. 1984;24:152–154. doi: 10.1111/j.1526-4610.1984.hed2403152.x. [PubMed] [Cross Ref]
151. Giacovazzo M, Martelletti P, Romiti A, Gallo MF, Iuvara E, Valeri M, Piazza A, Adorno D, Monaco PI, Casciani CU. Genetic markers of cluster headache and the links with the lithium salts therapy. Int J Clin Pharmacol Res. 1986;6:19–22. [PubMed]
152. Sjöstrand C, Giedratis V, Ekbom K, Waldenlind E, Hillert J. CACNA1A gene polymorphisms in cluster headache. Cephalalgia. 2001;21:953–958. [PubMed]
153. Haan J, Vliet JA, Kors EE, Terwindt GM, Vermeulen FL, Maagdenberg AM, Frants RR, Ferrari MD. No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. Cephalalgia. 2001;21:959–962. [PubMed]
154. Sjöstrand C, Modin H, Masterman T, Ekbom K, Waldenlind E, Hillert J. Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia. 2002;22:758–764. [PubMed]
155. Aridon P, D’Andrea G, Rigamonti A, Leone M, Casari G, Bussone G. Elusive amines and cluster headache: mutational analysis of trace amine receptor cluster on chromosome 6q23. Neurol Sci. 2004;25(Suppl 3):S279–S280. [PubMed]
156. Cevoli S, Mochi M, Pierangeli G, Zanigni S, Grimaldi D, Bonavina G, Torelli P, Manzoni GC, Cortelli P, Montagna P (2008) Investigation of the T3111C CLOCK gene polymorphism in cluster headache. J Neurol Feb 20 [Epub ahead of print]
157. Rainero I, Rivoiro C, Gallone S, Valfrè W, Ferrero M, Angilella G, Rubino E, Martino P, Savi L, Lo Giudice R, Pinessi L. Lack of association between the 3092 T→C Clock gene polymorphism and cluster headache. Cephalalagia. 2005;25:1078–1081.
158. Rainero I, Rivoiro C, Rubino E, Milli V, Valfrè W, Martino P, Lo Giudice R, Angilella G, Savi L, Gallone S, Pinessi L. Prevalence of HFE (hemochromatosis) gene mutations in patients with cluster headache. Headache. 2005;45:1219–1223. [PubMed]
159. Rainero I, Gallone S, Valfrè W, Ferrero M, Angilella G, Rivoiro C, Rubino E, Martino P, Savi L, Ferrone M, Pinessi L. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology. 2004;63:1286–1288. [PubMed]
160. Schürks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology. 2006;66:1917–1919. [PubMed]
161. Baumber L, Sjöstrand C, Leone M, Harty H, Bussone G, Hillert J, Trembath RC, Russell MB. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology. 2006;66:1888–1893. [PubMed]
162. Siow HC, Young WB, Peres MF, Rozen TD, Silberstein SD. Hemiplegic cluster. Headache. 2002;42:136–139. [PubMed]
163. Sjöstrand C, Duvefelt K, Steinberg A, Remahl IN, Waldenlind E, Hillert J. Gene expression profiling in cluster headache: a pilot microarray study. Headache. 2006;46:1518–1534. [PubMed]
164. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005;102:10604–10609. [PubMed]
165. Oommen AM, Griffin JB, Sarath G, Zempleni J. Roles for nutrients in epigenetic events. J Nutr Biochem. 2005;16:74–77. [PubMed]
166. Champagne FA, Francis DD, Mar A, Meaney MJ. Variations in maternal care in the rat as a mediating influence for the effects of environment on development. Physiol Behav. 2003;79:359–371. [PubMed]
167. Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci. 2004;7:847–854. [PubMed]
168. Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, Szyf M. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci. 2005;25:11045–11054. [PubMed]
169. Karten YJ, Olariu A, Cameron HA. Stress in early life inhibits neurogenesis in adulthood. Trends Neurosci. 2005;28:171–172. [PubMed]
170. Vicentic A, Francis D, Moffett M, Lakatos A, Rogge G, Hubert GW, Harley J, Kuhar MJ. Maternal separation alters serotonergic transporter densities and serotonergic 1A receptors in rat brain. Neuroscience. 2006;140:355–365. [PubMed]
171. Burlet G, Fernette B, Blanchard S, Angel E, Tankosic P, Maccari S, Burlet A. Antenatal glucocorticoids blunt the functioning of the hypothalamic–pituitary–adrenal axis of neonates and disturb some behaviors in juveniles. Neuroscience. 2005;133:221–230. [PubMed]
172. Yoshihara T, Otsuki Y, Yamazaki A, Honma S, Yamasaki Y, Honma K. Maternal deprivation in neonatal rats alters the expression of circadian system under light–dark cycles and restricted daily feeding in adulthood. Physiol Behav. 2005;85:646–654. [PubMed]
173. Levenson JM, Sweatt JD. Epigenetic mechanisms in memory formation. Nat Rev Neurosci. 2005;6:108–118. [PubMed]
174. Hong EJ, West AE, Greenberg ME. Transcriptional control of cognitive development. Curr Opin Neurobiol. 2005;15:21–28. [PubMed]
175. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry. 2004;55:965–970. [PubMed]
176. Gottesman II, Hanson DR. Human development: biological and genetic processes. Annu Rev Psychol. 2005;56:263–286. [PubMed]
177. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 2004;20:350–358. [PubMed]
178. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8:253–262. [PubMed]
179. Vercelli D. Genetics, epigenetics, and the environment: switching, buffering, releasing. J Allergy Clin Immunol. 2004;113:381–386. [PubMed]
180. Savi L, Buccheri R, Tambornini A, Martino P, Albasi C, Pinessi L. Attachment styles and headache. J Headache Pain. 2005;6:254–257. [PMC free article] [PubMed]
181. Rossi P, Di Lorenzo G, Malpezzi MG, Di Lorenzo C, Cesarino F, Faroni J, Siracusano A, Troisi A. Depressive symptoms and insecure attachment as predictors of disability in a clinical population of patients with episodic and chronic migraine. Headache. 2005;45:561–570. [PubMed]
182. Ventegodt S, Flensborg-Madsen T, Andersen NJ, Merrick J. Events in pregnancy, delivery, and infancy and long-term effects on global quality of life: results from the Copenhagen Perinatal Birth Cohort 1959–61. Med Sci Monit. 2005;11:CR357–CR365. [PubMed]
183. Blau JN. Migraine: theories of pathogenesis. Lancet. 1992;339:1202–1209. [PubMed]
184. Welch KM. Migraine: a biobehavioural disorder. Cephalalgia. 1986;6:103–110. [PubMed]
185. Montagna P, Cortelli P (2008) Migraine and the autonomic nervous system. In: Low PA (ed) Clinical autonomic disorders: evaluation and management. Lippincott, Williams and Wilkins, Philadelphia (in press)
186. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123–137. [PubMed]
187. Blau JN. Behaviour during a cluster headache. Lancet. 1993;342:723–725. [PubMed]
188. Loder E. What is the evolutionary advantage of migraine? Cephalalgia. 2002;22:624–32. [PubMed]

Articles from The Journal of Headache and Pain are provided here courtesy of Springer